✦ LIBER ✦

Late recurrence after resection of stage I lung adenocarcinoma

✍ Scribed by Norihiro Kikuchi; Hiroaki Satoh; Kiyohisa Sekizawa; Shigemi Ishikawa

Book ID: 117035497
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 64 KB
Volume: 75
Category: Article
ISSN: 0003-4975
DOI: 10.1016/s0003-4975(02)04513-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metachronous cancers or late recurrences

Metachronous cancers or late recurrences after resection of stage I lung cancer

✍ Roberta Lenner; Alvin S Teirstein; Daniel J Krellenstein 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Second Primary Lung Cancers: Smokers Ver

Second Primary Lung Cancers: Smokers Versus Nonsmokers After Resection of Stage I Lung Adenocarcinoma

✍ Ripley, R. Taylor; McMillan, Robert R.; Sima, Camelia S.; Hasan, Saad M.; Ahmad, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 422 KB

Risk of Recurrence in Surgically Resecte

Risk of Recurrence in Surgically Resected Stage I Adenocarcinoma of the Lung: Histopathologic and Immunohistochemical Analysis

✍ Sukki Cho; Sook-Whan Sung; Sanghoon Jheon; Jin-Haeng Chung 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 246 KB

Risk of recurrence after surgical resect

Risk of recurrence after surgical resection of small-sized invasive lung adenocarcinoma

✍ Atsushi Morio; Hideaki Miyamoto; Hiroshi Izumi 📂 Article 📅 2005 🏛 Springer Japan 🌐 Japanese ⚖ 672 KB

Oligo-Recurrence From a Lung Adenocarcin

Oligo-Recurrence From a Lung Adenocarcinoma. Usefulness of Resection

✍ García Rodríguez, Miguel Emilio; Armas Pérez, Bárbaro Agustín; Armas Moredo, Kar 📂 Article 📅 2014 🏛 Elsevier Science 🌐 Spanish ⚖ 508 KB

Late recurrence of stage I malignant mel

Late recurrence of stage I malignant melanoma

✍ Mordechai Gutman; Joseph M. Klausner; Moshe Inbar; Ron R. Rozin 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB

Although the introduction of well-established risk factors has made the clinical course and prognosis of malignant melanoma disease much more predictable, in a considerable number of patients the disease's course is still not as expected. One group to which this applies are stage I melanoma patients